A highly attenuated vaccinia virus strain LC16m8-based vaccine for severe fever with thrombocytopenia syndrome

Single dose of a rVSV-based vaccine elicits complete protection against severe fever with thrombocytopenia syndrome virus

(2019) Fangfang Dong et al.   npj Vaccines

Fulminant myocarditis associated with severe fever with thrombocytopenia syndrome: a case report

(2019) Shotaro Miyamoto et al.   BMC INFECTIOUS DISEASES

Development of a SFTSV DNA vaccine that confers complete protection against lethal infection in ferrets

(2019) Jeong-Eun Kwak et al.   Nature Communications

A Novel System for Constructing a Recombinant Highly-Attenuated Vaccinia Virus Strain (LC16m8) Expressing Foreign Genes and Its Application for the Generation of LC16m8-Based Vaccines against Herpes Simplex Virus 2

(2018) Natsumi Omura et al.   JAPANESE JOURNAL OF INFECTIOUS DISEASES

Correlations between clinical features and death in patients with severe fever with thrombocytopenia syndrome

(2018) Jianhua Hu et al.   MEDICINE

A Single Dose of Modified Vaccinia Ankara expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal Ebola Virus Challenge

(2018) Arban Domi et al.   Scientific Reports

Current status of Severe Fever with Thrombocytopenia Syndrome vaccine development

(2018) Lisa M Reece et al.   Current Opinion in Virology

Vector-based genetically modified vaccines: Exploiting Jenner’s legacy

(2016) Bahar Ramezanpour et al.   VACCINE

Phylogeographic analysis of severe fever with thrombocytopenia syndrome virus from Zhoushan Islands, China: implication for transmission across the ocean

(2016) Yongfeng Fu et al.   Scientific Reports

Severe Fever with Thrombocytopenia Syndrome in South Korea, 2013-2015

(2016) Seong Jin Choi et al.   PLoS Neglected Tropical Diseases

Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome Virus

(2016) Hideki Tani et al.   mSphere

Epidemiological and Clinical Features of Severe Fever with Thrombocytopenia Syndrome in Japan, 2013–2014

(2016) Hirofumi Kato et al.   PLoS One

Epidemiological and clinical characteristics of severe fever with thrombocytopenia syndrome (SFTS) in China: an integrated data analysis

(2015) C.-T. GUO et al.   EPIDEMIOLOGY AND INFECTION

Crimean-Congo Hemorrhagic Fever

(2015) Sara Shayan et al.   Labmedicine

A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease

(2015) SD Dowall et al.   Human Vaccines & Immunotherapeutics

Crimean-Congo Hemorrhagic Fever

(2015) Sara Shayan et al.   LABORATORY MEDICINE

Prognostic value of clinical and immunological markers in acute phase of SFTS virus infection

(2014) Y.-P. Ding et al.   CLINICAL MICROBIOLOGY AND INFECTION

Sensitive and Specific PCR Systems for Detection of Both Chinese and Japanese Severe Fever with Thrombocytopenia Syndrome Virus Strains and Prediction of Patient Survival Based on Viral Load

(2014) Tomoki Yoshikawa et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Viral Particles Drive Rapid Differentiation of Memory B Cells into Secondary Plasma Cells Producing Increased Levels of Antibodies

(2014) F. Zabel et al.   JOURNAL OF IMMUNOLOGY

A Novel Vaccine against Crimean-Congo Haemorrhagic Fever Protects 100% of Animals against Lethal Challenge in a Mouse Model

(2014) Karen R. Buttigieg et al.   PLoS One

Age Is a Critical Risk Factor for Severe Fever with Thrombocytopenia Syndrome

(2014) Shujun Ding et al.   PLoS One

The First Identification and Retrospective Study of Severe Fever With Thrombocytopenia Syndrome in Japan

(2013) Toru Takahashi et al.   JOURNAL OF INFECTIOUS DISEASES

Systematic review of severe fever with thrombocytopenia syndrome:virology, epidemiology, and clinical characteristics

(2013) Shelan Liu et al.   REVIEWS IN MEDICAL VIROLOGY

Cytoplasmic tails of bunyavirus Gn glycoproteins—Could they act as matrix protein surrogates?

(2013) Tomas Strandin et al.   VIROLOGY

Fiji: an open-source platform for biological-image analysis

(2012) Johannes Schindelin et al.   NATURE METHODS

Cytokine and Chemokine Levels in Patients with Severe Fever with Thrombocytopenia Syndrome Virus

(2012) Baocheng Deng et al.   PLoS One

Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors

(2011) Stephen R Walsh et al.   Expert Review of Vaccines

Contributions of Antinucleoprotein IgG to Heterosubtypic Immunity against Influenza Virus

(2011) Mark W. LaMere et al.   JOURNAL OF IMMUNOLOGY

Safety and Immunogenicity of LC16m8, an Attenuated Smallpox Vaccine in Vaccinia-Naive Adults

(2011) J. S. Kennedy et al.   JOURNAL OF INFECTIOUS DISEASES

Fever with Thrombocytopenia Associated with a Novel Bunyavirus in China

(2011) Xue-Jie Yu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficient Cellular Release of Rift Valley Fever Virus Requires Genomic RNA

(2011) Mary E. Piper et al.   PLoS One

Metagenomic Analysis of Fever, Thrombocytopenia and Leukopenia Syndrome (FTLS) in Henan Province, China: Discovery of a New Bunyavirus

(2011) Bianli Xu et al.   PLoS Pathogens

Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL/6 mice

(2010) Chuan Li et al.   VACCINE

Depletion of CD4 T cells enhances immunotherapy for neuroblastoma after syngeneic HSCT but compromises development of antitumor immune memory

(2009) W. Jing et al.   BLOOD

Clinical and Immunological Response to Attenuated Tissue-Cultured Smallpox Vaccine LC16m8

(2009) Tomoya Saito   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION